B-precursor ALL
Clinical trials for B-precursor ALL explained in plain language.
Never miss a new study
Get alerted when new B-precursor ALL trials appear
Sign up with your email to follow new studies for B-precursor ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells show promise against tough childhood cancers
Disease control CompletedThis phase 1 trial tested a new therapy called CD22-CAR T cells in 134 children and young adults (ages 1-39) with B-cell leukemia or lymphoma that had not been cured by standard treatments. The therapy involves taking a patient's own white blood cells, modifying them in a lab to …
Matched conditions: B-PRECURSOR ALL
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy offers hope for older leukemia patients
Disease control CompletedThis study tested a new treatment approach for adults over 55 with a specific type of leukemia (B-precursor ALL). The goal was to see if using a targeted drug called blinatumomab along with a reduced dose of chemotherapy could help patients achieve remission with fewer side effec…
Matched conditions: B-PRECURSOR ALL
Phase 2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC